Melanotan 1 and EPP Similarly, in a phase 3 clinical trial in erythropoietic protoporphyria (EPP) patients, researchers examined whether a melanotan 1 implant could safely enable the patients to expose themselves to direct sunlight under the most intense natural conditions
[6] [1] Clinical studies, particularly in women with PCOS, have investigated the concurrent use of inositol and metformin without reporting serious safety concerns
However, drawing on data from a 2014 clinical trial, we can see that researchers dosed this peptide as follows [13]: 0.03 mg per kilogram of body weight per day Twice-daily intravenous infusions As with sermorelin, there is similarly strong research interest in the application of ipamorelin to improve body composition and performance in healthy individuals
Common side effects include nausea, mild stomach discomfort, and temporary fatigue, but these usually subside as your body adjusts
Presented for research literature review only Dhar K et al